Page 18 - டாரோ கூட்டாளிகள் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avinger, Inc.: Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported that more than 100 accounts have purchased Pantheris SV OCT-guided atherectomy catheters for the treatment of PAD since product launch in the third quarter of 2019. By combining real-time intravascular imaging with the precise control of directional atherectomy, our Pantheris SV device is proving to be an optimal choice for the treatment of peripheral artery disease in small vessels, commented Jeff Soinski, Avinger s President and CEO. Due to the low profile and longer length of the device, physicians are able to safely and effectively target the more distal regions of the vasculature below-the-knee (BTK), i

Redwood cityUnited statesMatt krepsTom davisJeff soinskiMark weinswigAvinger incExchange commission onSecurities exchangeDarrow associates investor relationsCompany lumivascularPeripheral artery diseaseSecurities actSecurities exchange actPrivate securities litigation reform actAnnual report